A recent video with Dr. Mascarenhas.
https://www.onclive.com/view/dr-mascare ... lofibrosis
REMINDER: The IMbark trial yielded a survival benefit despite having a number of patients drop out early based on lack of spleen response. Our upcoming Phase 3 trial (ImpactMF) patients will strive to remain in the trial in anticipation of a survival benefit.
Dr. Mascarenhas on the promise of Imetelstat (Onclive)
Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
-
- Posts: 128
- Joined: Thu Jun 18, 2020 5:48 pm
-
- Posts: 1670
- Joined: Fri Jul 20, 2018 5:13 pm
Re: Dr. Mascarenhas on the promise of Imetelstat (Onclive)
HI, thank you for posting this. I have been in medicine a long time. I can tell you that most of the advances I have seen are incremental. A true paradigm shift is a rare event. bp